Cargando…

Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population

BACKGROUND: Enhanced recovery after surgery (ERAS) programs have been proved effective for enhancing the clinical healing rate and reducing hospitalization cost in most countries of the world. It's a multi-model approach that designed to optimize perioperative pathway, attenuate the surgical st...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Xiaolin, Zhang, Bingyuan, Xing, Shichao, Tian, Liqi, Wang, Xiufang, Zhou, Meng, Li, Jiangfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113004/
https://www.ncbi.nlm.nih.gov/pubmed/30142819
http://dx.doi.org/10.1097/MD.0000000000011957
_version_ 1783350949886033920
author Jing, Xiaolin
Zhang, Bingyuan
Xing, Shichao
Tian, Liqi
Wang, Xiufang
Zhou, Meng
Li, Jiangfeng
author_facet Jing, Xiaolin
Zhang, Bingyuan
Xing, Shichao
Tian, Liqi
Wang, Xiufang
Zhou, Meng
Li, Jiangfeng
author_sort Jing, Xiaolin
collection PubMed
description BACKGROUND: Enhanced recovery after surgery (ERAS) programs have been proved effective for enhancing the clinical healing rate and reducing hospitalization cost in most countries of the world. It's a multi-model approach that designed to optimize perioperative pathway, attenuate the surgical stress response, and decrease postoperative complications. OBJECTIVE: The economic benefit from the application of ERAS to colorectal surgery has been demonstrated in China. However, such economic benefit of ERAS programs for hepatectomy hasn’t been clarified yet. This study was carried out to explore the clinical efficacy and cost effectiveness of ERAS in Chinese Han population after hepatectomy. METHODS: ERAS program was implemented in our department for hepatectomy in December 2016. In total, 79 consecutive patients after hepatectomy were chosen as ERAS group (ERAS protocol) in coming half year while 121 consecutive patients after hepatectomy were chosen as Pre-ERAS group (traditional protocol) in past half year. The operation time, intraoperative blood loss, length of hospital stay (LOS), complication, readmission, and hospitalization cost of 2 groups were compared. RESULTS: The LOS of ERAS group was 5.81 ± 1.79 days, significantly shorter than that of Pre-ERAS group (8.06 ± 3.40 d) (P = .000). The operation time was 168.03 ± 46.20 minutes for ERAS group and 175.41 ± 64.64 minutes for Pre-ERAS group respectively (P = .417). The intraoperative blood loss was 166.58 ± 194.13 mL (ERAS group) and 205.45 ± 279.63 mL (Pre-ERAS group) (P = .293). It should be noted that the hospitalization cost of ERAS group was 51556.18 ± 8926.05 Yuan (7835.05 ± 1355.45 US dollars), significantly less than that of Pre-ERAS group 60554.66 ± 15615.31 Yuan (9202.56 ± 2371.24 US dollars) (P = .000). The application of ERAS effectively saved 8998.48 Yuan (1367.51 US dollars) for each patient. CONCLUSIONS: ERAS implementation for hepatectomy surgery is safe and feasible for Chinese Han population. It eventually enhanced the clinical healing rate. The benefits from such programs include a reduction of the LOS, complication, and readmission rates. So each patient has access to better medical service. It effectively relieved the financial burden of patients. The benefits from such programs include a reduction of the hospitalization cost, especially in medication cost. So each patient can afford the diseases.
format Online
Article
Text
id pubmed-6113004
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-61130042018-09-07 Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population Jing, Xiaolin Zhang, Bingyuan Xing, Shichao Tian, Liqi Wang, Xiufang Zhou, Meng Li, Jiangfeng Medicine (Baltimore) Research Article BACKGROUND: Enhanced recovery after surgery (ERAS) programs have been proved effective for enhancing the clinical healing rate and reducing hospitalization cost in most countries of the world. It's a multi-model approach that designed to optimize perioperative pathway, attenuate the surgical stress response, and decrease postoperative complications. OBJECTIVE: The economic benefit from the application of ERAS to colorectal surgery has been demonstrated in China. However, such economic benefit of ERAS programs for hepatectomy hasn’t been clarified yet. This study was carried out to explore the clinical efficacy and cost effectiveness of ERAS in Chinese Han population after hepatectomy. METHODS: ERAS program was implemented in our department for hepatectomy in December 2016. In total, 79 consecutive patients after hepatectomy were chosen as ERAS group (ERAS protocol) in coming half year while 121 consecutive patients after hepatectomy were chosen as Pre-ERAS group (traditional protocol) in past half year. The operation time, intraoperative blood loss, length of hospital stay (LOS), complication, readmission, and hospitalization cost of 2 groups were compared. RESULTS: The LOS of ERAS group was 5.81 ± 1.79 days, significantly shorter than that of Pre-ERAS group (8.06 ± 3.40 d) (P = .000). The operation time was 168.03 ± 46.20 minutes for ERAS group and 175.41 ± 64.64 minutes for Pre-ERAS group respectively (P = .417). The intraoperative blood loss was 166.58 ± 194.13 mL (ERAS group) and 205.45 ± 279.63 mL (Pre-ERAS group) (P = .293). It should be noted that the hospitalization cost of ERAS group was 51556.18 ± 8926.05 Yuan (7835.05 ± 1355.45 US dollars), significantly less than that of Pre-ERAS group 60554.66 ± 15615.31 Yuan (9202.56 ± 2371.24 US dollars) (P = .000). The application of ERAS effectively saved 8998.48 Yuan (1367.51 US dollars) for each patient. CONCLUSIONS: ERAS implementation for hepatectomy surgery is safe and feasible for Chinese Han population. It eventually enhanced the clinical healing rate. The benefits from such programs include a reduction of the LOS, complication, and readmission rates. So each patient has access to better medical service. It effectively relieved the financial burden of patients. The benefits from such programs include a reduction of the hospitalization cost, especially in medication cost. So each patient can afford the diseases. Wolters Kluwer Health 2018-08-24 /pmc/articles/PMC6113004/ /pubmed/30142819 http://dx.doi.org/10.1097/MD.0000000000011957 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle Research Article
Jing, Xiaolin
Zhang, Bingyuan
Xing, Shichao
Tian, Liqi
Wang, Xiufang
Zhou, Meng
Li, Jiangfeng
Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population
title Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population
title_full Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population
title_fullStr Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population
title_full_unstemmed Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population
title_short Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population
title_sort cost-benefit analysis of enhanced recovery after hepatectomy in chinese han population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113004/
https://www.ncbi.nlm.nih.gov/pubmed/30142819
http://dx.doi.org/10.1097/MD.0000000000011957
work_keys_str_mv AT jingxiaolin costbenefitanalysisofenhancedrecoveryafterhepatectomyinchinesehanpopulation
AT zhangbingyuan costbenefitanalysisofenhancedrecoveryafterhepatectomyinchinesehanpopulation
AT xingshichao costbenefitanalysisofenhancedrecoveryafterhepatectomyinchinesehanpopulation
AT tianliqi costbenefitanalysisofenhancedrecoveryafterhepatectomyinchinesehanpopulation
AT wangxiufang costbenefitanalysisofenhancedrecoveryafterhepatectomyinchinesehanpopulation
AT zhoumeng costbenefitanalysisofenhancedrecoveryafterhepatectomyinchinesehanpopulation
AT lijiangfeng costbenefitanalysisofenhancedrecoveryafterhepatectomyinchinesehanpopulation